Astellas Enters into Definitive Agreement to Acquire Iveric Bio ...Middle East

PR Newswire - News
Astellas Enters into Definitive Agreement to Acquire Iveric Bio
-Companies to Create World-Class Ophthalmology Entity- -Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19, 2023- -Acquisition advances Astellas' Primary Focus on "Blindness & Regeneration"- -Acquisition price of US$40 per...

Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas Enters into Definitive Agreement to Acquire Iveric Bio )

Also on site :